Table 4.
Options | Efficacy | Hypos | Weight Change | Cost |
---|---|---|---|---|
Basal plus insulin regimen | Highest—with greater flexibility but increased complexity | +++ | ++ | Depends on the insulin used |
Premixed insulin regimen | Highest—low complexity but lesser flexibility | ++ | + | Depends on the insulin used |
Adding GLP-1RA | High—with highest flexibility and least complexity | + | Reduction | High compared to other two regimens |
CV: Cardiovascular; GLP-1RA: Glucagon-like peptide-1 receptor agonist.